From sleeping on staircases and bare floors to battling mosquitoes, rain, and exhaustion, relatives of patients admitted to teaching hospitals across the country are enduring harsh realities as they ...

OCEAN, said Albert, provides important risk-benefit data that doctors can now use in discussions with their patients. For ...

OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...

The results have potential to change clinical practice.NEW ORLEANS — Left atrial appendage closure in patients with atrial ...

In patients with atherosclerosis and/or diabetes without a prior heart attack or stroke, evolocumab cut the risk for first ...

For some people with high cholesterol, making lifestyle changes and taking routine statin medications may not be sufficient to help them reach their target cholesterol levels. For these patients, a ...

It’s the first study to show a PCSK9 inhibitor can reduce major events in high-risk patients who haven’t yet had one.

Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25% for at-risk patients who have never had a heart attack or stroke, according to results from a ...

Certain foods, nutrients, and supplements can help lower the risk of stroke. These include leafy greens, whole grains, folic ...

Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major ...

For most of us, the phrase "stroke of the eye" sounds like a metaphor. But for UK HealthCare's Jagannadha "Jay" Avasarala, ...

High blood pressure affected over 95% of heart attack patients in a recent study involving millions of people.